ACC cells treated with the combination of STA9090 and PIK75 arrested G2M phase of cell cycle arrest at a higher rate compared to those in single-drug treated and control groups, with a decreased expression of G2M cell cycle regulators such as CDK1 and cyclin B1 (Fig. 3f, 3g). Here, CDK1 is linked to adrenal cortex carcinoma.